Chair: Daniel Junius, President & CEO, ImmunoGen, Inc.
Vice Chair: Bradford Zakes, Chief Executive Officer, Cerevast Therapeutics, Inc.
Staff Contact: Joanne Duncan, Chief Financial Officer and Senior Vice President, Finance & Administration, jduncan(at)bio.org
Description: The committee oversees the audit function, the annual budget process, treasury management, and organizational financial compliance. The committee is chaired by the Treasurer of the BIO Board. The committee recommends an independent audit firm, reviews the scope and plan for the audit, reviews the results of the audit with the auditors, provides oversight of BIO’s internal control structure, and resolves any disagreements between the auditors and management. The committee also reviews the organization's investments with the outside investment advisor regularly.
Bradley Shurdut, Global Leader, Public & Government Affairs, Dow Agrosciences, LLC
Christian Nolet, Partner & Area Leader, Life Sciences, Ernst & Young
Christopher Standlee, EVP, Global Affairs, Abengoa Bioenergy
David Pyott, Chairman & CEO, Allergan, Inc.
H. Thomas Watkins, Chair Emeritus,BIO
Kristine Peterson, Chief Executive Officer, Valeritas, Inc.
Ronald Stotish, Chief Executive Officer, Aqua Bounty Technologies, Inc.